189 related articles for article (PubMed ID: 11350212)
1. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
Wang T; Shankar K; Bucci TJ; Warbritton A; Mehendale HM
Toxicol Appl Pharmacol; 2001 May; 173(1):27-37. PubMed ID: 11350212
[TBL] [Abstract][Full Text] [Related]
2. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1.
Wang T; Shankar K; Ronis MJ; Mehendale HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):473-9. PubMed ID: 10900221
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats.
Ramaiah SK; Apte U; Mehendale HM
Drug Metab Dispos; 2001 Aug; 29(8):1088-95. PubMed ID: 11454726
[TBL] [Abstract][Full Text] [Related]
6. Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide.
Devi SS; Philip BK; Warbritton A; Latendresse JR; Mehendale HM
Toxicology; 2006 Sep; 226(2-3):107-17. PubMed ID: 16901604
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
Shankar K; Vaidya VS; Wang T; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2003 Apr; 188(2):122-34. PubMed ID: 12691730
[TBL] [Abstract][Full Text] [Related]
8. Diet restriction enhances compensatory liver tissue repair and survival following administration of lethal dose of thioacetamide.
Ramaiah SK; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 1998 May; 150(1):12-21. PubMed ID: 9630448
[TBL] [Abstract][Full Text] [Related]
9. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
Devi SS; Mehendale HM
Toxicol Appl Pharmacol; 2005 Sep; 207(2):89-102. PubMed ID: 15953624
[TBL] [Abstract][Full Text] [Related]
10. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
Chanda S; Mangipudy RS; Warbritton A; Bucci TJ; Mehendale HM
Hepatology; 1995 Feb; 21(2):477-86. PubMed ID: 7843722
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in tissue repair permit survival of diet-restricted rats from an acute lethal dose of thioacetamide.
Ramaiah SK; Bucci TJ; Warbritton A; Soni MG; Mehendale HM
Toxicol Sci; 1998 Oct; 45(2):233-41. PubMed ID: 9848130
[TBL] [Abstract][Full Text] [Related]
12. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital.
Chilakapati J; Korrapati MC; Shankar K; Hill RA; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2007 Feb; 219(1):72-84. PubMed ID: 17234228
[TBL] [Abstract][Full Text] [Related]
13. Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.
Mangipudy RS; Rao PS; Mehendale HM
Environ Health Perspect; 1996 Jul; 104(7):744-9. PubMed ID: 8841760
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide.
Chilakapati J; Korrapati MC; Hill RA; Warbritton A; Latendresse JR; Mehendale HM
Toxicology; 2007 Feb; 230(2-3):105-16. PubMed ID: 17187915
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats.
Sawant SP; Dnyanmote AV; Mehendale HM
Toxicology; 2007 Apr; 232(3):200-15. PubMed ID: 17298859
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotection by dimethyl sulfoxide. III. Role of inhibition of the bioactivation and covalent bonding of chloroform.
Lind RC; Begay CK; Gandolfi AJ
Toxicol Appl Pharmacol; 2000 Jul; 166(2):145-50. PubMed ID: 10896856
[TBL] [Abstract][Full Text] [Related]
18. Temporal changes in tissue repair upon repeated exposure to thioacetamide.
Mangipudy RS; Mehendale HM
Toxicol Appl Pharmacol; 1998 Apr; 149(2):254-7. PubMed ID: 9571995
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of thioacetamide-treated type 1 diabetic rats.
Devi SS; Mehendale HM
Toxicol Appl Pharmacol; 2006 Apr; 212(1):69-78. PubMed ID: 16297948
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model.
Shaik IH; George JM; Thekkumkara TJ; Mehvar R
Pharm Res; 2008 Oct; 25(10):2231-42. PubMed ID: 18626753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
